BRIAN P FREEMAN M.D. NPI 1225141609

NPI Information

  • NPI: 1225141609
  • Provider Name: BRIAN P FREEMAN, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 411 LAUREL ST STE A300
    DES MOINES, IA
    ZIP 50314
  • Phone: (515) 282-2921

Map and Directions

Get Directions

NPI Details

Brian P Freeman, M.D. is a medical oncology internal medicine in Des Moines, IA with 20 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Brian P Freeman, M.D. NPI is 1225141609. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Graduation Year:2005

The provider's business location address is:

411 LAUREL ST STE A300
DES MOINES, IA
ZIP 50314-030
Phone: (515) 282-2921
Fax: (515) 643-8819

The NPI 1225141609 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Unclassified drugs (HCPCS:J3490)
  • Magnesium level (HCPCS:83735)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Hospital discharge day management, more than 30 minutes (HCPCS:99239)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)

The enumeration date for this NPI number is 8/17/2006 and was last updated on 2/5/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology36821IOWANo
2207R00000XInternal Medicine36821IOWANo
3207RX0202XInternal MedicineMedical OncologyMD-36821IOWAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.